Drugs for Herpes Labialis (Oral Herpes) Market Size By Regional Analysis(Europe, Asia Pacific, America, Middle East And Africa), By Demand & COVID-19 Impact Analysis, By Type, By Applications And Forecasts 2023 - 2030
Report Overview
The market research report is created with a compilation of analytical research based on historic records, current statistics, and future predictions. The report contains details on the leading players operating in the Drugs for Herpes Labialis (Oral Herpes) market including various factors related to and dependent influencing the market growth.
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.
The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.
Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.
North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.
Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Drugs for Herpes Labialis (Oral Herpes) market is valued at 2040 million US$ in 2020 and will reach 3030 million US$ by the end of 2030, growing at a CAGR of 5.1% during 2023-2030. The objectives of this study are to define, segment, and project the size of the Drugs for Herpes Labialis (Oral Herpes) market based on company, product type, end user and key regions.
This report studies the global market size of Drugs for Herpes Labialis (Oral Herpes) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Drugs for Herpes Labialis (Oral Herpes) in these regions.
This research report categorizes the global Drugs for Herpes Labialis (Oral Herpes) market by top players/brands, region, type and end user. This report also studies the global Drugs for Herpes Labialis (Oral Herpes) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The report is prepared using analytical methods such as SWOT (strengths, weaknesses, opportunities, and threats)) analysis, PESTEL Analysis, Porter\'s Five Force Analysis, and value chain analysis. These methods provide a clear view of the market structure and analyze competition at a global level. They also provide detailed information on each segment in the global Drugs for Herpes Labialis (Oral Herpes) market.
The aim of the report is to interpret the market sizes of various segments and countries for the forecast period. The study includes the qualitative and quantitative analysis of the market. The report analyses the Drugs for Herpes Labialis (Oral Herpes) market on a regional and global level with a deep analysis of macro-and micro-economic factors impacting the growth of the market. This report also includes market information related to the latest industry trends, market developments, and analysis of products and end users contributing to market growth. An in-depth study of the current market scenario, major driving factors, and restraining factors for the market are also included in the report.
The Drugs for Herpes Labialis (Oral Herpes) market report includes information related to market segmentation, market size and revenue forecasts, and regional forecasts along with information about the leading market players operating in the market, company revenue shares and, their recent developments. The market is classified regionally on country-level into North America, Europe, Asia Pacific, the Middle East and Africa, and South America.
Scope of the Drugs for Herpes Labialis (Oral Herpes) Market:
The major competitors working in the market are:
, GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon, Luoxin, Med shine, Bayer (Campho Phenique), Blistex, Kelun Group, Hikma, Haiwang, Carmex, Cipher
Market by Order Type
Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
Market size by End User
External Use
Oral
Injection
Regions Covered in the Report are:
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Rest of the World
The information about the Drugs for Herpes Labialis (Oral Herpes) market is obtained from several sources such as company websites, journals, annual reports, which were then assessed and verified by the industry experts. The information is represented in the form of diagrams, charts, pie charts, and infographics, which helps in a better understanding of the market.
Objectives of Drugs for Herpes Labialis (Oral Herpes) Market Report:
- To analyze the factors driving the market growth including supply chain analysis, price analysis along with other analytical methods
- To provide an in-depth analysis of the Drugs for Herpes Labialis (Oral Herpes) market with information on various segment and sub-segments
- To provide a regional analysis and global analysis for the Drugs for Herpes Labialis (Oral Herpes) market size and their forecasts
- To provide strategic profiles of the key players operating in the Drugs for Herpes Labialis (Oral Herpes) market, their key competencies, and market competition
- To provide a competitive scenario about the key factors driving, restraining, and challenging the market growth.
- The impact of COVID-19 pandemic on the Drugs for Herpes Labialis (Oral Herpes) market
Target Audiences for Drugs for Herpes Labialis (Oral Herpes) Market:
- Investors
- Investment Bankers
- Key Consulting Companies and Advisors
- Venture Capitalists
- Large, Medium-sized, and Small enterprises
Customization:
We also provide customized reports according to customer\'s specific requirements. We also provide customization for regional and country-level reports individually.
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
- Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
- Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
- Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
- Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
- Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.